TABLE 1.

Characteristics of symptomatic adults seeking outpatient medical care or clinical SARS‐CoV‐2 testing by SARS‐CoV‐2 status, US Flu VE Network, October 2021–February 2022

	Negative SARS‐CoV‐2 Participants with CLI		Positive SARS‐CoV‐2 Participants with CLI
	N	Col %	N	Col %	P value a
Total	2208	100	1639	100
Age group, y					0.06
18–49	1347	61	1027	63
50–64	544	25	419	26
≥65	317	14	193	12
Site					<0.01
California	322	15	164	10
Michigan	166	8	188	11
Pennsylvania	311	14	320	20
Tennessee	269	12	186	11
Texas	262	12	159	10
Washington	296	13	110	7
Wisconsin	582	26	512	31
Sex b					<0.01
Female	1485	67	1017	62
Male	720	33	618	38
Race/ethnicity c					<0.01
Black, non‐Hispanic	87	4	119	7
Hispanic	221	10	134	8
Other, non‐Hispanic	198	9	128	8
White, non‐Hispanic	1676	77	1218	76
Self‐reported chronic medical condition d					0.77
No	1514	70	1138	70
Yes	652	30	480	30
High‐risk exposure					<0.01
No	1273	58	706	43
Yes	935	42	933	57
Self‐reported prior infection e					<0.01
No	1841	84	1450	89
Yes (6 missing)	350	16	179	11	0.12
<3 months ago	194	56	110	63
≥3 months ago	154	44	65	37
Product among vaccinated (2 and 3 doses)
Moderna	670	36	368	31
Pfizer‐BioNTech	1165	62	784	67
Combination	42	2	20	2
Fever f					<0.01
No	1233	56	649	40
Yes	950	44	968	60

Abbreviation: CLI, COVID‐19‐like illness.

^a P value for chi‐square statistic.

^b Seven participants missing data on sex.

^c Sixty‐six participants missing data on race and/or ethnicity.

^d Sixty‐three participants missing data on chronic medical condition.

^e Twenty‐seven participants missing data on self‐reported prior SARS‐CoV‐2 infection.

^f Forty‐seven participants missing data on presence of fever.